All products are shipped same-day from Canada with third-party purity verification
In SURPASS-2, tirzepatide caused vomiting in 6-10% of participants across dose levels, while semaglutide 1 mg caused vomiting in 8%
Being mindful of these variables and of high-calorie sides, dips, and sugary drinks allows you to enjoy pizza while maintaining a clearer picture of your daily intake
Week-by-Week Overview Week 1 on GLP-1s: Resetting Appetite and Learning New Fullness Cues What the medication is doing: GLP-1s slow gastric emptying and lower hunger signals, so most people feel full sooner and stay full longer during the first week on a GLP-1 medication
The patient stays on the dose they reached their goal at (1.7 mg, 2.4 mg, or 7.2 mg of semaglutide
This personalized approach helps maximize the benefits while maintaining safety throughout the treatment